# MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)

> **NCT03078374** · NA · UNKNOWN · sponsor: **Institute for Clinical and Experimental Medicine** · enrollment: 15 (actual)

## Conditions studied

- Heart Failure
- Cardiovascular Diseases

## Interventions

- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT03078374
- **Lead sponsor:** Institute for Clinical and Experimental Medicine
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-11
- **Primary completion:** 2022-01
- **Final completion:** 2022-10
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03078374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03078374, "MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03078374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*